NEW YORK, July 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:US Clinical Laboratory Testing Market Assessment
The US represents an attractive destination for healthcare services' market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending. It is estimated that the market for clinical lab testing in the US reached to the mark of US$ 61 Billion in 2011 backed by factors, such as aging population, active private sector participation and rising awareness level. With the emergence of new technologies, the market is likely to register further to an optimum CAGR in future.
Currently, the market is dominated by routine testing followed by esoteric/molecular pathology tests and anatomic pathology. The future, however, holds significant promise for drug of abuse and anatomic pathology testing. The future growth in the US anatomic pathology (AP) segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type with special emphasis on their future performance.
The US market for clinical laboratory diagnostics is highly fragmented with large number of labs offering services in different states of the country. Some players, however, have leading edge in comparison to other companies. Quest diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities. Our report entitled "US Clinical Laboratory Testing Market Assessment" provides an in-depth insight into the operations, services, M&A activities, financial performance and strengths and weaknesses of the key players in order to gauge their attractiveness in terms of investment and future participation in the market.
The report is an outcome of an in-depth research and prudent analysis of the US clinical laboratory testing market that emphasizes the reliability of data provided and presentation. It covers all the key aspects of market and investigates trends that are likely to impact the industry in the long run. Segment-wise analysis focuses upon the relevant information and key developments. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market or make decisions regarding investment.1. Analyst View2. Research Methodology3. US Clinical Laboratory Testing Industry3.1 Current and Future Market Analysis to 20153.2 Market Division by Type of Tests3.3 Market Division by Type of Lab4. Consolidation: Picking up Pace in Laboratory Testing5. Regulatory Framework5.1 Role of CLIA5.2 Payment Mechanism5.3 Drug Testing5.4 Health Insurance Portability and Accountability Act of 1996 (HIPAA)5.5 Laboratory Developed Tests (LDTs)6. Competitive Landscape6.1 Quest Diagnostics6.1.1 Business Overview6.1.2 Key Products and Services6.1.3 Financial Overview6.1.4 M&A Activity6.1.5 Strengths and Weaknesses6.2 Laboratory Corporation of America (LabCorp)6.2.1 Business Overview6.2.2 Key Products and Services6.2.3 Financial Overview6.2.4 M&A Activity6.2.5 Strengths and Weaknesses6.3 Bio-Reference Laboratories6.3.1 Business Overview6.3.2 Key Products and Services6.3.3 Financial Overview6.3.4 M&A Activity6.3.5 Strengths and Weaknesses6.4 Sonic Healthcare USA6.4.1 Business Overview6.4.2 Financial Overview6.4.3 M&A Activity6.4.4 Strengths and Weaknesses6.5 ARUP Laboratories6.5.1 Business Overview6.5.2 Key Products and Services6.5.3 Strengths and Weaknesses
List of Figures:
Figure 3-1: Clinical Laboratory Testing Market (Billion US$), 2011-2015Figure 3-2: Clinical Laboratory Testing Market by Type of Test (%), 2011Figure 3-3: Clinical Laboratory Testing Market by Type of Lab (%), 2011Figure 4-1: Number of Closed M&A Deals in Lab Testing Market (2001-2011)Figure 5-1: Medicare Spending on Clinical Lab Fee Schedule (%), 2010Figure 6-1: Sonic Healthcare USA - Revenue (Million AUD), 2010 & 2011
List of Tables:
Table 6-1: Quest Diagnostics - Key Products and ServicesTable 6-2: Quest Diagnostics - Financial Performance (Million US$), 2009-2011Table 6-3: Quest Diagnostics - Key M&As ActivitiesTable 6-4: LabCorp - Key Products and ServicesTable 6-5: LabCorp - Financial Performance (Million US$), 2009-2011Table 6-6: LabCorp - Key M&As ActivitiesTable 6-7: Bio-Reference Labs - Key Products and ServicesTable 6-8: Bio-Reference Labs - Financial Performance (Million US$), 2009-2011Table 6-9: Sonic Healthcare USA - Key M&As ActivitiesTable 6-10: ARUP Laboratories - Key Products and ServicesTo order this report:In Vitro Diagnostic Industry: US Clinical Laboratory Testing Market Assessment
MoreMarket Research Report
Check ourIndustry Analysis and Insights
Intl: +1 805-652-2626